Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glycaemic Control”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Testing effectiveness (Phase 2)Study completedNCT01193218
What this trial is testing

Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 547
Large-scale testing (Phase 3)Study completedNCT01392677
What this trial is testing

Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea

Who this might be right for
Type 2 Diabetes MellitusHigh HbA1c LevelInadequate Glycaemic Control
AstraZeneca 311
Large-scale testing (Phase 3)Study completedNCT01214239
What this trial is testing

Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 300
Large-scale testing (Phase 3)Study completedNCT01210001
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 499
Post-approval studies (Phase 4)Study completedNCT02471404
What this trial is testing

Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea

Who this might be right for
Type 2 Diabetes MellitusInadequate Glycaemic Control
AstraZeneca 939
Post-approval studies (Phase 4)Study completedNCT01438814
What this trial is testing

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 689
Large-scale testing (Phase 3)Study completedNCT00622284
What this trial is testing

Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,560
Post-approval studies (Phase 4)Study completedNCT02589639
What this trial is testing

Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 269
Post-approval studies (Phase 4)Study completedNCT00118937
What this trial is testing

Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet

Who this might be right for
Diabetes Mellitus, Type 1
Steno Diabetes Center Copenhagen 100
Post-approval studies (Phase 4)Study completedNCT01175811
What this trial is testing

A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 402
Large-scale testing (Phase 3)Study completedNCT01009580
What this trial is testing

Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 447
Large-scale testing (Phase 3)Study completedNCT01368081
What this trial is testing

Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,162
Large-scale testing (Phase 3)UnknownNCT01257334
What this trial is testing

Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea

Who this might be right for
Type 2 Diabetes
Taipei Medical University WanFang Hospital 1,390
Large-scale testing (Phase 3)Study completedNCT01164501
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency
Boehringer Ingelheim 741
Large-scale testing (Phase 3)Study completedNCT01215097
What this trial is testing

Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 306
Large-scale testing (Phase 3)Temporarily pausedNCT01257412
What this trial is testing

Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 375
Post-approval studies (Phase 4)Study completedNCT02240680
What this trial is testing

Linagliptin as Add on to Basal Insulin in the Elderly

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 302
Large-scale testing (Phase 3)Study completedNCT00661362
What this trial is testing

Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 570
Large-scale testing (Phase 3)Study completedNCT01042977
What this trial is testing

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease

Who this might be right for
Type 2 Diabetes MellitusCardiovascular DiseaseInadequate Glycaemic Control
AstraZeneca 964
Large-scale testing (Phase 3)Study completedNCT00601250
What this trial is testing

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 701
Next Page